Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
188 studies found for:    matrix metalloproteinases
Show Display Options
Rank Status Study
1 Completed The Expression of Matrix Metalloproteinase 13, Tissue Inhibitor of Metalloproteinases 3, and Calcium-sensing Receptor in Human Trabecular Meshwork
Condition: Open-angle Glaucoma
Intervention: Procedure: trabeculectomy
2 Completed Case-control Study on Matrix Metalloproteinase Levels in Tissue in Patients With Keloid Scar
Condition: Keloid
Intervention: Procedure: Removal of Keloid
3 Recruiting Matrix Metalloproteinases in Atherosclerosis of Chronic Kidney Disease
Condition: Diabetic Nephropathy
4 Completed Effect of Caffeic Acid Phenethyl Ester as a Matrix Metalloproteinase Inhibitor: Randomized Controlled Clinical Trial
Conditions: Matrix Metalloproteinase Inhibitors;   Composite Resins
Interventions: Drug: total-etch adhesive;   Drug: CAPE-T;   Drug: self-etch adhesive;   Drug: CAPE-S
5 Completed A Phase I Study of Oral COL-3 (NSC-683551), a Matrix Metalloproteinase Inhibitor, in Patients With Refractory Metastatic Cancer
Conditions: Lymphoma;   Melanoma;   Neoplasm Metastasis;   Renal Cell Carcinoma
Intervention: Drug: COL-3
6 Completed Matrix Metalloproteinases After Surgery and/or Radiofrequency Ablation in Patients With Liver Metastases From Colorectal Cancer
Conditions: Colorectal Cancer;   Metastatic Cancer
Interventions: Other: laboratory biomarker analysis;   Procedure: cryosurgery;   Procedure: radiofrequency ablation;   Procedure: therapeutic conventional surgery
7 Completed Role of Matrix Metalloproteinases (MMPs) and Tissue Inhibitors of Metalloproteinases (TIMPs) in Children With Myocarditis
Condition: Myocarditis
8 Completed The Role of Matrix Metalloproteinases (MMPs) in Orthodontic Tooth Movement
Conditions: Tooth, Impacted;   Molar, Third
Intervention: Procedure: Orthodontic treatment
9 Completed Matrix Metalloproteinases and Diabetic Nephropathy
Conditions: Diabetes Mellitus, Type 1;   Diabetic Nephropathy
10 Withdrawn Measurement of Matrix Metalloproteinase Activation Post Myocardial Infarction
Condition: Acute Myocardial Infarction
11 Completed Sputum Matrix Metalloproteinases (MMP) mRNA and Montelukast
Condition: Asthma
Intervention: Drug: montelukast
12 Completed The Effect of Doxycycline on Matrix Metalloproteinase Expression and Activity in the Abdominal Aneurysm
Condition: Aortic Aneurysm, Abdominal
Intervention: Drug: doxycycline
13 Completed Polymorphisms in the Human Matrix Metalloproteinase Genes MMP1, MMP3, and MMP9: Genetic Risk Factors of Primary Open Angle Glaucoma?
Condition: Glaucoma
Intervention: Procedure: Blood Sample
14 Completed A Comparative Study of Volume Replacement With HES 130/0.4 Versus Ringer's Lactate (RL) Regarding Their Effects on Inflammatory Biomarkers (Cytokines and Matrix Metalloproteinases) Responses to Major Abdominal Surgery.
Condition: Postoperative Inflammation
Interventions: Other: Ringer's Lactate;   Other: HES 130/0.4 and Ringer's Lactate
15 Completed
Has Results
Activated MMP-8 as Diagnostic Test for Periodontitis
Condition: Generalized Chronic Periodontitis
Intervention: Other: no intervention provided
16 Completed Cytokine and MMP Levels in Gingival Crevicular Fluid in the Treatment of Localized Gingival Recessions
Condition: Gingival Recession
Interventions: Procedure: Connective tissue graft;   Procedure: Platelet Rich Fibrin
17 Completed MMP Polymorphisms and Acute Coronary Syndromes
Condition: Unstable Angina
18 Completed Matrix Metalloproteinases in Patients With Critical Limb Ischemia Undergoing Surgical Revascularization
Conditions: Critical Limb Ischemia;   Extracellular Matrix Alteration;   Peripheral Revascularisation
Interventions: Procedure: Polytetrafluoroethylene (PTFE) bypass grafting.;   Procedure: Autogenous vein bypass grafting
19 Completed Plasma Levels of Matrix Metalloproteinases (MMPs) and Degree of DNA Fragmentation in Pseudoexfoliation (PEX) Glaucoma
Conditions: Pseudoexfoliation Syndrome;   Glaucoma
20 Recruiting Point of Care Testing of Inflammatory Markers in Tears
Condition: Dry Eye Syndrome
Interventions: Other: Eye inflammation;   Other: Without eye inflammation

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years